A phase I study of bortezomib and temozolomide in patients with advanced solid tumors

被引：0
|
作者：
J. Portnow
P. Frankel
S. Koehler
P. Twardowski
S. Shibata
C. Martel
R. Morgan
M. Cristea
W. Chow
D. Lim
V. Chung
K. Reckamp
L. Leong
T. W. Synold
机构：
[1] City of Hope,Department of Medical Oncology
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Bortezomib; Temozolomide; Phase I; Pharmacokinetics; Hepatic enzyme-inducing anticonvulsants;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：505 / 514
页数：9
相关论文
共 50 条
  • [41] A phase I study of vorinostat in combination with bortezomib in refractory solid tumors
    Schelman, W. R.
    Kolesar, J.
    Schell, K.
    Marnocha, R.
    Eickhoff, J.
    Alberti, D.
    Wilding, G.
    Bailey, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Phase 1 Trial of Gemcitabine With Bortezomib in Elderly Patients With Advanced Solid Tumors
    Bommakanti, Satya V.
    Dudek, Arkadiusz Z.
    Khatri, Amit
    Kirstein, Mark N.
    Gada, Purvi D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (06): : 597 - 602
  • [43] Phase I clinical trial of temozolomide and methoxyamine (TRC-102) in patients with advanced solid tumors.
    Eads, Jennifer Rachel
    Krishnamurthi, Smitha S.
    Saltzman, Joel N.
    Meropol, Neal J.
    Bokar, Joseph A.
    Gibbons, Joseph
    Koon, Henry B.
    Sharma, Neelesh
    Savvides, Panayiotis
    Pink, John
    Xu, Yan
    Beumer, Jan Hendrik
    Fu, Pingfu
    Beatty, Kristi
    Kane, Donna
    Rodal, Mary Beth
    Czalkiewicz, Julianne
    Riendeau, John
    Gerson, Stanton L.
    Dowlati, Afshin
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Phase I study of temozolomide in paediatric patients with advanced cancer
    Estlin, EJ
    Lashford, L
    Ablett, S
    Price, L
    Gowing, R
    Gholkar, A
    Kohler, J
    Lewis, IJ
    Morland, B
    Pinkerton, CR
    Stevens, R
    Mott, M
    Stevens, R
    Newell, DR
    Walker, D
    Dicks-Mireaux, C
    McDowell, H
    Reidenberg, P
    Statkevich, P
    Marco, A
    Batra, V
    Dugan, N
    Pearson, ADJ
    BRITISH JOURNAL OF CANCER, 1998, 78 (05) : 652 - 661
  • [45] Phase I study of temozolomide in paediatric patients with advanced cancer
    EJ Estlin
    L Lashford
    S Ablett
    L Price
    R Gowing
    A Gholkar
    J Kohler
    IJ Lewis
    B Morland
    CR Pinkerton
    MCG Stevens
    M Mott
    R Stevens
    DR Newell
    D Walker
    C Dicks-Mireaux
    H McDowell
    P Reidenberg
    P Statkevich
    A Marco
    V Batra
    M Dugan
    ADJ Pearson
    British Journal of Cancer, 1998, 78 : 652 - 661
  • [46] Temozolomide in patients with advanced cancer: Phase I and pharmacokinetic study
    Rudek, MA
    Donehower, RC
    Statkevich, P
    Batra, VK
    Cutler, DL
    Baker, SD
    PHARMACOTHERAPY, 2004, 24 (01): : 16 - 25
  • [47] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [48] A phase I study of tivantinib in combination with temsirolimus in patients with advanced solid tumors
    Christos E. Kyriakopoulos
    Amy M. Braden
    Jill M. Kolesar
    Jens C. Eickhoff
    Howard H. Bailey
    Jennifer Heideman
    Glenn Liu
    Kari B. Wisinski
    Investigational New Drugs, 2017, 35 : 290 - 297
  • [49] A phase I study of ridaforolimus in adult Chinese patients with advanced solid tumors
    Liu, Lian
    Zhang, Wen
    Li, Wenhua
    Lv, Fangfang
    Xia, Zuguang
    Zhang, Sheng
    Liu, Wen
    Zandvliet, Anthe S.
    Waajen, Sylvia
    Zhang, Li Xin
    Yan, Li
    Li, Jin
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [50] A Phase I study of sorafenib in combination with capecitabine in patients with advanced, solid tumors
    Awada, A.
    Gil, T.
    Burk, K.
    Vanhamme, J.
    Mancini, I.
    Besse, T.
    Brendel, E.
    Matthys, A.
    Piccart, M.
    Hendlisz, A.
    EJC SUPPLEMENTS, 2006, 4 (12): : 33 - 34
12345